Personalized peptide vaccination for advanced colorectal cancer

被引:7
作者
Sasada, Tetsuro [1 ,2 ]
Kibe, Shiro [3 ]
Akagi, Yoshito [3 ]
Itoh, Kyogo [1 ]
机构
[1] Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 830, Japan
[2] Kanagawa Canc Ctr, Res Inst, Canc Vaccine Ctr, Yokohama, Kanagawa 2410815, Japan
[3] Kurume Univ, Dept Surg, Kurume, Fukuoka 830, Japan
关键词
biomarker; colorectal cancer; IL-6; peptide vaccine; personalized vaccine;
D O I
10.1080/2162402X.2015.1005512
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have developed a novel approach in cancer immunotherapy, the personalized peptide vaccination (PPV), in which human leukocyte antigen (HLA)-matched peptides are selected on the basis of preexisting host immunity before vaccination. Recently, we demonstrated the feasibility of PPV in previously treated patients with advanced colorectal cancer, thus warranting further clinical development of this approach.
引用
收藏
页数:3
相关论文
共 9 条
[1]   Immunologic biomarkers as correlates of clinical response to cancer immunotherapy [J].
Disis, Mary L. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (03) :433-442
[2]   Improved Endpoints for Cancer Immunotherapy Trials [J].
Hoos, Axel ;
Eggermont, Alexander M. M. ;
Janetzki, Sylvia ;
Hodi, F. Stephen ;
Ibrahim, Ramy ;
Anderson, Aparna ;
Humphrey, Rachel ;
Blumenstein, Brent ;
Old, Lloyd ;
Wolchok, Jedd .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18) :1388-1397
[3]   Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer [J].
Kibe, Shiro ;
Yutani, Shigeru ;
Motoyama, Satoru ;
Nomura, Takanobu ;
Tanaka, Natsuki ;
Kawahara, Akihiko ;
Yamaguchi, Tomohiko ;
Matsueda, Satoko ;
Komatsu, Nobukazu ;
Miura, Masatomo ;
Hinai, Yudai ;
Hattori, Satoshi ;
Yamada, Akira ;
Kage, Masayoshi ;
Itoh, Kyogo ;
Akagi, Yoshito ;
Sasada, Tetsuro .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (12) :1154-1162
[4]   Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination [J].
Komatsu, Nobukazu ;
Matsueda, Satoko ;
Tashiro, Kousuke ;
Ioji, Tetsuya ;
Shichijo, Shigeki ;
Noguchi, Masanori ;
Yamada, Akira ;
Doi, Atsushi ;
Suekane, Shigetaka ;
Moriya, Fukuko ;
Matsuoka, Kei ;
Kuhara, Satoru ;
Itoh, Kyogo ;
Sasada, Tetsuro .
CANCER, 2012, 118 (12) :3208-3221
[5]   Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine [J].
Noguchi, Masanori ;
Sasada, Tetsuro ;
Itoh, Kyogo .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (05) :919-929
[6]   A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer [J].
Noguchi, Masanori ;
Kakuma, Tatsuyuki ;
Uemura, Hirotsugu ;
Nasu, Yasutomo ;
Kumon, Hiromi ;
Hirao, Yasuhiko ;
Moriya, Fukuko ;
Suekane, Shigetaka ;
Matsuoka, Kei ;
Komatsu, Nobukazu ;
Shichijo, Shigeki ;
Yamada, Akira ;
Itoh, Kyogo .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (07) :1001-1009
[7]   Personalized Peptide Vaccine for Treatment of Advanced Cancer [J].
Sasada, Tetsuro ;
Yamada, Akira ;
Noguchi, Masanori ;
Itoh, Kyogo .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (21) :2332-2345
[8]   Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen-A24 With Recurrent or Progressive Glioblastoma Multiforme [J].
Terasaki, Mizuhiko ;
Shibui, Soichiro ;
Narita, Yoshitaka ;
Fujimaki, Takamitsu ;
Aoki, Tomokazu ;
Kajiwara, Koji ;
Sawamura, Yutaka ;
Kurisu, Kaoru ;
Mineta, Toshihiro ;
Yamada, Akira ;
Itoh, Kyogo .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :337-344
[9]   Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis [J].
Yoshitomi, Munehiro ;
Yutani, Shigeru ;
Matsueda, Satoko ;
Ioji, Tetsuya ;
Komatsu, Nobukazu ;
Shichijo, Shigeki ;
Yamada, Akira ;
Itoh, Kyogo ;
Sasada, Tetsuro ;
Kinoshita, Hisafumi .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (03) :463-469